Donald Cockcroft, a Professor in the Division of Respirology, Critical Care and Sleep Medicine in the College of Medicine, has been elected a Fellow of the Canadian Academy of Health Sciences. Dr. Cockcroft has made several significant contributions to asthma research and helped develop one of the earliest sets of asthma guidelines. He developed a method for methacholine challenge that is widely used around the world to assess airway responsiveness and diagnose asthma. His research was also important in the recognition of asthma as an inflammatory disease. His work with the AllerGen Network of Centres of Excellence Clinical Investigator Collaborative has leveraged industry funding for clinical research, standardized testing protocols for potential asthma drugs, and helped identify potentially effective treatments at an early stage of development. Dr. Cockcroft is a former president of the Saskatchewan Thoracic Society and the Canadian Thoracic Society, a Fellow of the American Academy of Allergy, Asthma and Immunology, the American College of Chest Physicians, and the American College of Allergy, Asthma and Immunology. In 2006, he was awarded a Career Achievement Award in Clinical Health Research from the Saskatchewan Health Research Foundation.
Dr. Donald Cockcroft is a renowned and highly cited expert in asthma who has made significant contributions to respiratory medicine. His pioneering achievements have played a key role in our understanding of asthma and have impacted asthma diagnosis and management. He has been heavily involved in developing asthma guidelines with organizations such as the Canadian Thoracic Society. He is one of the founders of the AllerGen Network of Centres of Excellence Clinical Investigator Collaborative, a world-leading initiative to identify and accelerate development of potential new asthma medications. He also developed the widely used Cockcroft-Gault formula for predicting creatinine clearance.